The following Bill of Lading record outlines a container shipment imported into the US by BREAKTHRU BEVERAGE. This shipment is registered as coming from DIAGEO SCOTLAND LTD via Anvers,Belgium with logistic notifications handled by TRANS AMERICAN CHB, INC. Manifest records show a quanitity of 1146 CAS with a total weight of 18794 Kilograms arrived on 2020-02-23 via the vessel MSC KRYSTAL to the port of Baltimore, Maryland. Cargo includes products identified as net weight: 8.496 kilograms commodity code 2 2083030 caol ila 75cl 12y 06x01 abv43 .00% shipper's reference number: 6477679/0111 632217 exporter's reference number: 194803540 40.
| Carrier Code | MEDU |
| Vessel | MSC KRYSTAL [PA] |
| Departure Port | Anvers,Belgium |
| Landing Port | Baltimore, Maryland |
| Manifest Qty | 1146 CAS |
| Manifest Weight | 18794 Kilograms |
| Manifest Dimension | 32 Cubic Meters |
| Place of Receipt | GRANGEMOUTH |
| Conveyance ID | 9372470 [IMO Number/Lloyds Number] |
| Transportation Mode | Vessel, containerized |
| Arrival Date | 2020-02-23 |
| Container # | Pieces | Description |
|---|---|---|
| MEDU7548046 | 2 | NET WEIGHT: 8.496 KILOGRAMS COMMODITY CODE 2 2083030 CAOL ILA 75CL 12Y 06X01 ABV43 .00% SHIPPER'S REFERENCE NUMBER: 6477679/0111 632217 EXPORTER'S REFERENCE NUMBER: 194803540 40 |
| MEDU7548046 | 32 | NET WEIGHT: 136.896 KILOGRAMS COMMODITY CODE 22083071 BUCHANAN SR 75CL 18Y 06X01 ABV 40.00% |
| MEDU7548046 | 56 | NET WEIGHT: 478.464 KILOGRAMS COMMODITY CODE 22083071 JW BLACK 37.5C 12Y 24X01 ABV 40.00% |
| MEDU7548046 | 64 | NET WEIGHT: 546.816 KILOGRAMS COMMODITY CODE 22083071 JW RED 75CL 12X01 ABV40.00 % |
| MEDU7548046 | 96 | NET WEIGHT: 410.688 KILOGRAMS COMMODITY CODE 22083071 JW BLUE 75CL 06X01 ABV40.00 % |
| MEDU7548046 | 3 | NET WEIGHT: 3191.040 KILOGRAMS COMMODITY CODE 22083071 JW RED 1.75L 06X01 ABV40. 00% |
| MEDU7548046 | 576 | NET WEIGHT: 5660.928 KILOGRAMS COMMODITY CODE 22085011 TANQ LNDN GIN 1.75L 06X01 ABV47. 30% |
| MEDU7548046 | NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME SAME SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME | |
| MEDU7548046 | NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) | |
| MEDU7548046 | SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME | |
| MEDU7548046 | NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME SAME SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME | |
| MEDU7548046 | NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) | |
| MEDU7548046 | SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME NA PO: 4903613839 CUSTOMER PO: 4500751544 FDA PC: 21 CFR 170.3 (N)(2) SAME |
| Master BOL | House BOL | Voyage Number | Bill Type | Manifest # | Update / Run Date |
|---|---|---|---|---|---|
| MEDUUK866116 | () | 006W | Regular Bill | 1 | 2020-02-05 / 2020-02-24 |